NEW YORK, Oct. 21, 2022 /PRNewswire/ — During the forecast period, the Drug Substance Manufacturing Packaging industry will see an increase in spending of around USD 87.76 Billion. However, the majority of this expansion will be driven by only a few regions. Furthermore, due to their supplier base, North America, Europeand APAC will have the most effect on the supply side.
Download our free sample report today to get a detailed understanding of the major forces driving this market across geographies.
Key Drug Substance Manufacturing Packaging Sourcing and Procurement Report Highlights:
1. Market growth 2022-2026: USD 87.76 Billion
2. Growth momentum & CAGR: Accelerate at a CAGR of 6.38
3. Top Pricing Models: Volume-based pricing model, Project-based pricing model, and Value-based pricing model
4. Key consumer countries: North America